Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

OBJECTIVE:In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it remains to be determined whether finasteride concentrations may affect prostate cancer risk....

Full description

Bibliographic Details
Main Authors: Cindy H Chau, Douglas K Price, Cathee Till, Phyllis J Goodman, Xiaohong Chen, Robin J Leach, Teresa L Johnson-Pais, Ann W Hsing, Ashraful Hoque, Catherine M Tangen, Lisa Chu, Howard L Parnes, Jeannette M Schenk, Juergen K V Reichardt, Ian M Thompson, William D Figg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4425512?pdf=render

Similar Items

Similar Items